PortalPublikationenThe impact of ultra-high-density mapping on long-term outcom...

The impact of ultra-high-density mapping on long-term outcome after catheter ablation of ventricular tachycardia

Standard

The impact of ultra-high-density mapping on long-term outcome after catheter ablation of ventricular tachycardia. / Schleberger, Ruben; Schwarzl, Jana M; Moser, Julia; Nies, Moritz; Höller, Alexandra; Münkler, Paula; Dinshaw, Leon; Jungen, Christiane; Lemoine, Marc D; Maury, Philippe; Sacher, Frederic; Martin, Claire A; Wong, Tom; Estner, Heidi L; Jaïs, Pierre; Willems, Stephan; Eickholt, Christian; Meyer, Christian.

in: SCI REP-UK, Jahrgang 12, Nr. 1, 9139, 01.06.2022.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Schleberger, R, Schwarzl, JM, Moser, J, Nies, M, Höller, A, Münkler, P, Dinshaw, L, Jungen, C, Lemoine, MD, Maury, P, Sacher, F, Martin, CA, Wong, T, Estner, HL, Jaïs, P, Willems, S, Eickholt, C & Meyer, C 2022, 'The impact of ultra-high-density mapping on long-term outcome after catheter ablation of ventricular tachycardia', SCI REP-UK, Jg. 12, Nr. 1, 9139. https://doi.org/10.1038/s41598-022-12918-7

APA

Schleberger, R., Schwarzl, J. M., Moser, J., Nies, M., Höller, A., Münkler, P., Dinshaw, L., Jungen, C., Lemoine, M. D., Maury, P., Sacher, F., Martin, C. A., Wong, T., Estner, H. L., Jaïs, P., Willems, S., Eickholt, C., & Meyer, C. (2022). The impact of ultra-high-density mapping on long-term outcome after catheter ablation of ventricular tachycardia. SCI REP-UK, 12(1), [9139]. https://doi.org/10.1038/s41598-022-12918-7

Vancouver

Schleberger R, Schwarzl JM, Moser J, Nies M, Höller A, Münkler P et al. The impact of ultra-high-density mapping on long-term outcome after catheter ablation of ventricular tachycardia. SCI REP-UK. 2022 Jun 1;12(1). 9139. https://doi.org/10.1038/s41598-022-12918-7

Bibtex

@article{f1ed2899275a46c5bcbc27585228e55d,
title = "The impact of ultra-high-density mapping on long-term outcome after catheter ablation of ventricular tachycardia",
abstract = "Ultra-high-density (UHD) mapping can improve scar area detection and fast activation mapping in patients undergoing catheter ablation of ventricular tachycardia (VT). The aim of the present study was to compare the outcome after VT ablation guided by UHD and conventional point-by-point 3D-mapping. The acute and long-term ablation outcome of 61 consecutive patients with UHD mapping (64-electrode mini-basket catheter) was compared to 61 consecutive patients with conventional point-by-point 3D-mapping using a 3.5 mm tip catheter. Patients, whose ablation was guided by UHD mapping had an improved 24-months outcome in comparison to patients with conventional mapping (cumulative incidence estimate of the combination of recurrence or disease-related death of 52.4% (95% confidence interval (CI) [36.9-65.7]; recurrence: n = 25; disease-related death: n = 4) versus 69.6% (95% CI [55.9-79.8]); recurrence: n = 31; disease-related death n = 11). In a cause-specific Cox proportional hazards model, UHD mapping (hazard ratio (HR) 0.623; 95% CI [0.390-0.995]; P = 0.048) and left ventricular ejection fraction > 30% (HR 0.485; 95% CI [0.290-0.813]; P = 0.006) were independently associated with lower rates of recurrence or disease-related death. Other procedural parameters were similar in both groups. In conclusion, UHD mapping during VT ablation was associated with fewer VT recurrences or disease-related deaths during long-term follow-up in comparison to conventional point-by-point mapping. Complication rates and other procedural parameters were similar in both groups.",
keywords = "Body Surface Potential Mapping, Catheter Ablation/adverse effects, Humans, Stroke Volume, Tachycardia, Ventricular, Treatment Outcome, Ventricular Function, Left",
author = "Ruben Schleberger and Schwarzl, {Jana M} and Julia Moser and Moritz Nies and Alexandra H{\"o}ller and Paula M{\"u}nkler and Leon Dinshaw and Christiane Jungen and Lemoine, {Marc D} and Philippe Maury and Frederic Sacher and Martin, {Claire A} and Tom Wong and Estner, {Heidi L} and Pierre Ja{\"i}s and Stephan Willems and Christian Eickholt and Christian Meyer",
note = "{\textcopyright} 2022. The Author(s).",
year = "2022",
month = jun,
day = "1",
doi = "10.1038/s41598-022-12918-7",
language = "English",
volume = "12",
journal = "SCI REP-UK",
issn = "2045-2322",
publisher = "NATURE PUBLISHING GROUP",
number = "1",

}

RIS

TY - JOUR

T1 - The impact of ultra-high-density mapping on long-term outcome after catheter ablation of ventricular tachycardia

AU - Schleberger, Ruben

AU - Schwarzl, Jana M

AU - Moser, Julia

AU - Nies, Moritz

AU - Höller, Alexandra

AU - Münkler, Paula

AU - Dinshaw, Leon

AU - Jungen, Christiane

AU - Lemoine, Marc D

AU - Maury, Philippe

AU - Sacher, Frederic

AU - Martin, Claire A

AU - Wong, Tom

AU - Estner, Heidi L

AU - Jaïs, Pierre

AU - Willems, Stephan

AU - Eickholt, Christian

AU - Meyer, Christian

N1 - © 2022. The Author(s).

PY - 2022/6/1

Y1 - 2022/6/1

N2 - Ultra-high-density (UHD) mapping can improve scar area detection and fast activation mapping in patients undergoing catheter ablation of ventricular tachycardia (VT). The aim of the present study was to compare the outcome after VT ablation guided by UHD and conventional point-by-point 3D-mapping. The acute and long-term ablation outcome of 61 consecutive patients with UHD mapping (64-electrode mini-basket catheter) was compared to 61 consecutive patients with conventional point-by-point 3D-mapping using a 3.5 mm tip catheter. Patients, whose ablation was guided by UHD mapping had an improved 24-months outcome in comparison to patients with conventional mapping (cumulative incidence estimate of the combination of recurrence or disease-related death of 52.4% (95% confidence interval (CI) [36.9-65.7]; recurrence: n = 25; disease-related death: n = 4) versus 69.6% (95% CI [55.9-79.8]); recurrence: n = 31; disease-related death n = 11). In a cause-specific Cox proportional hazards model, UHD mapping (hazard ratio (HR) 0.623; 95% CI [0.390-0.995]; P = 0.048) and left ventricular ejection fraction > 30% (HR 0.485; 95% CI [0.290-0.813]; P = 0.006) were independently associated with lower rates of recurrence or disease-related death. Other procedural parameters were similar in both groups. In conclusion, UHD mapping during VT ablation was associated with fewer VT recurrences or disease-related deaths during long-term follow-up in comparison to conventional point-by-point mapping. Complication rates and other procedural parameters were similar in both groups.

AB - Ultra-high-density (UHD) mapping can improve scar area detection and fast activation mapping in patients undergoing catheter ablation of ventricular tachycardia (VT). The aim of the present study was to compare the outcome after VT ablation guided by UHD and conventional point-by-point 3D-mapping. The acute and long-term ablation outcome of 61 consecutive patients with UHD mapping (64-electrode mini-basket catheter) was compared to 61 consecutive patients with conventional point-by-point 3D-mapping using a 3.5 mm tip catheter. Patients, whose ablation was guided by UHD mapping had an improved 24-months outcome in comparison to patients with conventional mapping (cumulative incidence estimate of the combination of recurrence or disease-related death of 52.4% (95% confidence interval (CI) [36.9-65.7]; recurrence: n = 25; disease-related death: n = 4) versus 69.6% (95% CI [55.9-79.8]); recurrence: n = 31; disease-related death n = 11). In a cause-specific Cox proportional hazards model, UHD mapping (hazard ratio (HR) 0.623; 95% CI [0.390-0.995]; P = 0.048) and left ventricular ejection fraction > 30% (HR 0.485; 95% CI [0.290-0.813]; P = 0.006) were independently associated with lower rates of recurrence or disease-related death. Other procedural parameters were similar in both groups. In conclusion, UHD mapping during VT ablation was associated with fewer VT recurrences or disease-related deaths during long-term follow-up in comparison to conventional point-by-point mapping. Complication rates and other procedural parameters were similar in both groups.

KW - Body Surface Potential Mapping

KW - Catheter Ablation/adverse effects

KW - Humans

KW - Stroke Volume

KW - Tachycardia, Ventricular

KW - Treatment Outcome

KW - Ventricular Function, Left

U2 - 10.1038/s41598-022-12918-7

DO - 10.1038/s41598-022-12918-7

M3 - SCORING: Journal article

C2 - 35650230

VL - 12

JO - SCI REP-UK

JF - SCI REP-UK

SN - 2045-2322

IS - 1

M1 - 9139

ER -